We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.12%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+39.12%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.88%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$1.39B
Cap. Flow
+$1.53B
Cap. Flow %
42.15%
Top 10 Hldgs %
29.82%
Holding
356
New
150
Increased
17
Reduced
25
Closed
81

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$161M
2
TSLA icon
Tesla
TSLA
+$113M
3
MSFT icon
Microsoft
MSFT
+$105M
4
NVDA icon
NVIDIA
NVDA
+$101M
5
GFS icon
GlobalFoundries
GFS
+$79.4M

Top Sells

Rank Stock Value
1
ITT icon
ITT
ITT
+$78.1M
2
ULS icon
UL Solutions
ULS
+$70.9M
3
SYM icon
Symbotic
SYM
+$46.3M
4
NNE
Nano Nuclear Energy
NNE
+$38.2M
5
KGS icon
Kodiak Gas Services
KGS
+$34M

Sector Composition

Rank Sector Weight
1 Industrials 17.1%
2 Technology 14.38%
3 Consumer Discretionary 11.01%
4 Financials 8.33%
5 Healthcare 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEVO
201
M Evo Global Acquisition Corp II
MEVO
$399M
$985K 0.03%
+100,000
New +$986K
ARTC
202
Art Technology Acquisition Corp
ARTC
$982K 0.03%
+100,000
New +$980K
CADL icon
203
Candel Therapeutics
CADL
$859M
$980K 0.03%
+200,000
New +$1.09M
JCAP
204
Jefferson Capital
JCAP
$1.48B
$962K 0.03%
50,000
+15,000
+43% +$317K
SPAI
205
Safe Pro Group Inc
SPAI
$127M
$953K 0.03%
250,000
-36,000
-13% -$175K
NTSK
206
Netskope Inc
NTSK
$6.39B
$849K 0.02%
100,000
-150,000
-60% -$1.86M
AVR
207
Anteris Technologies
AVR
$916M
$833K 0.02%
+150,000
New +$862K
DRUG
208
Bright Minds Biosciences
DRUG
$750M
$803K 0.02%
+11,000
New +$885K
PPHC
209
Public Policy Holding Co
PPHC
$306M
$785K 0.02%
+60,000
New +$751K
EIKN
210
Eikon Therapeutics
EIKN
$598M
$741K 0.02%
+70,000
New +$936K
BTGO
211
BitGo Holdings
BTGO
$668M
$658K 0.02%
+80,000
New +$875K
LMRI
212
Lumexa Imaging Holdings
LMRI
$1.15B
$645K 0.02%
75,000
-50,000
-40% -$686K
IRON icon
213
Disc Medicine
IRON
$3.03B
$639K 0.02%
10,000
– –
PXED
214
Phoenix Education Partners
PXED
$980M
$629K 0.02%
20,000
– –
LIFE
215
Ethos Technologies Inc
LIFE
$2.17B
$559K 0.02%
+50,000
New +$591K
ROIV icon
216
Roivant Sciences
ROIV
$26.1B
$540K 0.01%
+19,500
New +$501K
AMBQ
217
Ambiq Micro
AMBQ
$1.56B
$508K 0.01%
20,000
– –
SVIVU
218
Spring Valley Acquisition Corp IV Units
SVIVU
$207M
$508K 0.01%
+50,000
New +$506K
CMIIU
219
Columbus Circle Capital Corp II Unit
CMIIU
$497K 0.01%
+50,000
New +$499K
MESH
220
Meshflow Acquisition Corp
MESH
$433M
$495K 0.01%
+50,000
New +$495K
COSO
221
CoastalSouth Bancshares
COSO
$332M
$492K 0.01%
20,000
– –
IXHL icon
222
Incannex Healthcare
IXHL
$39.2M
$489K 0.01%
+162,855
New +$1.18M
AKTS
223
Aktis Oncology
AKTS
$1.38B
$447K 0.01%
+25,000
New +$485K
MPLT
224
MapLight Therapeutics
MPLT
$533M
$407K 0.01%
20,000
– –
HSDT icon
225
Solana Company
HSDT
$99.3M
$386K 0.01%
223,051
-140,268
-39% -$341K
7 8
9
10 11

Similar funds

KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
YCM
Yaupon Capital Management New York $5.08B AUM 53.49% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
GIBU
Gulf International Bank (UK) London, United Kingdom $5.07B AUM 41.86% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $5.13B AUM 11.51% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Ghisallo Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Ghisallo Capital Management held 356 positions worth $3.63B, up 62% from $2.24B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ghisallo Capital Management deployed $1.53B of net new capital in Q1 2026, opening 150 new positions and adding to 17 existing holdings. Its largest new stake was Tesla: 275,000 shares worth $102M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was UL Solutions, an estimated $70.9M trimmed.

  • Ghisallo Capital Management's largest Q1 2026 buy was Tesla: 275,000 shares worth $102M.
  • Ghisallo Capital Management added most to Medline Inc in Q1 2026, an estimated $161M increase.
  • Ghisallo Capital Management's biggest Q1 2026 reduction was UL Solutions, cutting an estimated $70.9M.
  • Ghisallo Capital Management fully exited ITT in Q1 2026, selling an estimated $78.1M.
  • Ghisallo Capital Management's ten largest holdings make up 30% of its $3.63B portfolio in Q1 2026.
  • Ghisallo Capital Management opened 150 new positions and closed 81 in Q1 2026.
  • Ghisallo Capital Management's portfolio value rose 62% quarter-over-quarter to $3.63B.

Based on Ghisallo Capital Management's 13F filing for Q1 2026, filed 15 May 2026.